Posaconazole Mono- or Combination Therapy for Treatment of Murine Zygomycosis

Ashraf S. Ibrahim, Teclegiorgis Gebremariam, Julie Schwartz, John E. Edwards, Brad Spellberg

Antimicrobial Agents and Chemotherapy · 2008 · 106 citations · 13 references

DOIFull text

Open access

Concepts

Abstract

We compared the efficacy of combination posaconazole-liposomal amphotericin B (LAmB) therapy to monotherapy with either drug in diabetic ketoacidotic or neutropenic mice with disseminated zygomycosis caused by Rhizopus oryzae. Combination therapy was no better than LAmB alone, and posaconazole monotherapy did not improve survival or reduce fungal burden versus placebo.

References

13